Lv5
930 积分 2020-12-26 加入
Preclinical Development of an Anti-NaPi2b (SLC34A2) Antibody–Drug Conjugate as a Therapeutic for Non–Small Cell Lung and Ovarian Cancers
5小时前
待确认
NaPi2b expression in a large surgical Non-Small Cell Lung Cancer (NSCLC) cohort
5小时前
已完结
Independent radiologic review of AURELIA, a phase 3 trial of bevacizumab plus chemotherapy for platinum-resistant recurrent ovarian cancer
2个月前
已完结
Final results of a phase 3 study of trebananib plus weekly paclitaxel in recurrent ovarian cancer (TRINOVA-1): Long-term survival, impact of ascites, and progression-free survival-2
2个月前
已完结
50P Can we learn from failures? A systematic review and metanalysis of phase III trials in platinum resistant ovarian cancer
2个月前
已完结
B7-H4 (DD-O110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration
2个月前
已完结
Immunoexpression of B7-H3 in endometrial cancer: Relation to tumor T-cell infiltration and prognosis
2个月前
已完结
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup
2个月前
已完结
Progress in endometrial cancer: Contributions of the former Gynecologic Oncology Group
2个月前
已完结
Endometrial cancer
2个月前
已完结
皖公网安备34019202002308
